Free Trial

The Pennant Group, Inc. (NASDAQ:PNTG) Shares Sold by Wasatch Advisors LP

The Pennant Group logo with Medical background

Wasatch Advisors LP lowered its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG - Free Report) by 1.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,035,355 shares of the company's stock after selling 11,214 shares during the period. Wasatch Advisors LP owned approximately 3.01% of The Pennant Group worth $27,458,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Franklin Resources Inc. lifted its holdings in The Pennant Group by 26.6% in the 3rd quarter. Franklin Resources Inc. now owns 18,347 shares of the company's stock worth $638,000 after buying an additional 3,859 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in The Pennant Group by 68.4% in the third quarter. JPMorgan Chase & Co. now owns 205,922 shares of the company's stock valued at $7,351,000 after purchasing an additional 83,664 shares during the last quarter. Barclays PLC grew its stake in The Pennant Group by 375.0% during the 3rd quarter. Barclays PLC now owns 49,101 shares of the company's stock valued at $1,753,000 after purchasing an additional 38,763 shares in the last quarter. Geode Capital Management LLC increased its holdings in The Pennant Group by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 682,132 shares of the company's stock worth $24,357,000 after purchasing an additional 2,963 shares during the last quarter. Finally, Principal Financial Group Inc. boosted its stake in shares of The Pennant Group by 14.5% during the 3rd quarter. Principal Financial Group Inc. now owns 12,626 shares of the company's stock valued at $451,000 after buying an additional 1,597 shares during the last quarter. 85.88% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have commented on PNTG. Stephens reiterated an "overweight" rating and set a $38.00 price objective on shares of The Pennant Group in a research note on Wednesday, April 2nd. Truist Financial decreased their price target on The Pennant Group from $32.00 to $28.00 and set a "hold" rating for the company in a research note on Friday, March 7th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $34.80.

Get Our Latest Research Report on PNTG

The Pennant Group Stock Performance

Shares of NASDAQ PNTG traded up $0.41 during midday trading on Tuesday, hitting $24.91. The company's stock had a trading volume of 35,482 shares, compared to its average volume of 225,185. The company has a debt-to-equity ratio of 0.58, a quick ratio of 1.12 and a current ratio of 1.12. The Pennant Group, Inc. has a 1-year low of $20.11 and a 1-year high of $37.13. The firm's fifty day moving average price is $24.72 and its 200-day moving average price is $28.07. The firm has a market cap of $864.93 million, a P/E ratio of 36.63, a P/E/G ratio of 2.24 and a beta of 1.73.

The Pennant Group Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Recommended Stories

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Should You Invest $1,000 in The Pennant Group Right Now?

Before you consider The Pennant Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.

While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Big Week Reveals a Rare Growth Story in a Shaky Market
Buy the Fear: 3 Down Stocks That Could 10x Your Profits
Congress Bought THESE Stocks as Tariffs Tanked the Market

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines